Healthcare provider profile · identity verified

Elisabeth Abdin

Internal Medicine · DAVIS, CA · NPI 1124391941

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	139
Amlodipine Besylate	Amlodipine Besylate	337	88
Levothyroxine Sodium	Levothyroxine Sodium	318	71
Losartan Potassium	Losartan Potassium	287	83
Gabapentin	Gabapentin	215	60
Metoprolol Succinate	Metoprolol Succinate	202	59
Escitalopram Oxalate	Escitalopram Oxalate	198	48
Omeprazole	Omeprazole	191	52
Lisinopril	Lisinopril	184	49
Eliquis	Apixaban	151	36
Rosuvastatin Calcium	Rosuvastatin Calcium	150	47
Carvedilol	Carvedilol	130	27
Metformin Hcl	Metformin Hcl	128	32
Furosemide	Furosemide	125	39
Pantoprazole Sodium	Pantoprazole Sodium	123	34
Famotidine	Famotidine	108	31
Metformin Hcl Er	Metformin Hcl	108	34
Simvastatin	Simvastatin	100	29
Trazodone Hcl	Trazodone Hcl	100	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	98	17
Duloxetine Hcl	Duloxetine Hcl	97	20
Albuterol Sulfate Hfa	Albuterol Sulfate	96	42
Sertraline Hcl	Sertraline Hcl	93	18
Alendronate Sodium	Alendronate Sodium	85	32
Potassium Chloride	Potassium Chloride	84	26
Ozempic	Semaglutide	79	19
Tramadol Hcl	Tramadol Hcl	77	16
Alprazolam	Alprazolam	75	16
Allopurinol	Allopurinol	74	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	17
Spironolactone	Spironolactone	66	20
Atenolol	Atenolol	64	19
Donepezil Hcl	Donepezil Hcl	62	16
Finasteride	Finasteride	62	18
Citalopram Hbr	Citalopram Hydrobromide	58	16
Montelukast Sodium	Montelukast Sodium	57	16
Pravastatin Sodium	Pravastatin Sodium	57	16
Hydrochlorothiazide	Hydrochlorothiazide	56	17
Baclofen	Baclofen	55	13
Myrbetriq	Mirabegron	54	13
Tamsulosin Hcl	Tamsulosin Hcl	54	15
Triamcinolone Acetonide	Triamcinolone Acetonide	53	30
Propranolol Hcl	Propranolol Hcl	48	15
Cephalexin	Cephalexin	47	25
Bupropion Xl	Bupropion Hcl	46	12
Hydroxyzine Hcl	Hydroxyzine Hcl	45	12
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	11
Jardiance	Empagliflozin	43	16
Estradiol	Estradiol	42	14
Fluticasone Propionate	Fluticasone Propionate	41	18
Diclofenac Sodium	Diclofenac Sodium	37	suppressed
Trulicity	Dulaglutide	37	14
Benazepril Hcl	Benazepril Hcl	36	suppressed
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Glipizide Er	Glipizide	36	suppressed
Buspirone Hcl	Buspirone Hcl	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Prednisone	Prednisone	32	18
Naproxen	Naproxen	30	12
Diazepam	Diazepam	29	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	29	12
Warfarin Sodium	Warfarin Sodium	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	11
Calcitriol	Calcitriol	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	22
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Ondansetron Odt	Ondansetron	26	14
Sure Comfort Pen Needle	Pen Needle, Diabetic	26	suppressed
Acyclovir	Acyclovir	25	suppressed
Azelastine Hcl	Azelastine Hcl	25	14
Azithromycin	Azithromycin	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Ibuprofen	Ibuprofen	23	14
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	11
Linzess	Linaclotide	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Valsartan	Valsartan	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Temazepam	Temazepam	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Lactulose	Lactulose	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Constulose	Lactulose	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Modafinil	Modafinil	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Ramelteon	Ramelteon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error